In acute myeloid leukemia (AML), ~30% of patients harbor mutations in Fms-related receptor tyrosine kinase 3 (FLT3) which usually results in internal tandem duplications (FLT3-ITD)—thus allowing AML cells to proliferate84. The gene discussed is FLT3; the disease is acute myeloid leukemia.